251 related articles for article (PubMed ID: 31018569)
1. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
3. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
[TBL] [Abstract][Full Text] [Related]
4. Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G
Choi JS; Cho YY
Biochem Biophys Res Commun; 2023 Jan; 642():66-74. PubMed ID: 36566564
[TBL] [Abstract][Full Text] [Related]
5. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.
Peng C; Zhu F; Wen W; Yao K; Li S; Zykova T; Liu K; Li X; Ma WY; Bode AM; Dong Z
J Biol Chem; 2012 Jul; 287(31):25881-92. PubMed ID: 22685297
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
Ahmad A; Zhang W; Wu M; Tan S; Zhu T
Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
[TBL] [Abstract][Full Text] [Related]
8. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
[TBL] [Abstract][Full Text] [Related]
9. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
[TBL] [Abstract][Full Text] [Related]
10. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
Kim KS; Kim J; Oh N; Kim MY; Park KS
Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
[TBL] [Abstract][Full Text] [Related]
11. RSK2-induced stress tolerance enhances cell survival signals mediated by inhibition of GSK3β activity.
Lee CJ; Lee MH; Lee JY; Song JH; Lee HS; Cho YY
Biochem Biophys Res Commun; 2013 Oct; 440(1):112-8. PubMed ID: 24055036
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
14. Ribosomal S6 kinase 2-forkhead box protein O4 signaling pathway plays an essential role in melanogenesis.
Jeung D; Lee GE; Chen W; Byun J; Nam SB; Park YM; Lee HS; Kang HC; Lee JY; Kim KD; Hong YS; Lee CJ; Kim DJ; Cho YY
Sci Rep; 2024 Apr; 14(1):9440. PubMed ID: 38658799
[TBL] [Abstract][Full Text] [Related]
15. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
Cho YY
Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.
Godeny MD; Sayeski PP
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1308-17. PubMed ID: 16723511
[TBL] [Abstract][Full Text] [Related]
17. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
[TBL] [Abstract][Full Text] [Related]
18. Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention.
Yoo SM; Cho SJ; Cho YY
J Cancer Prev; 2015 Sep; 20(3):165-71. PubMed ID: 26473154
[TBL] [Abstract][Full Text] [Related]
19. Essential role of RSK2 in c-Fos-dependent osteosarcoma development.
David JP; Mehic D; Bakiri L; Schilling AF; Mandic V; Priemel M; Idarraga MH; Reschke MO; Hoffmann O; Amling M; Wagner EF
J Clin Invest; 2005 Mar; 115(3):664-72. PubMed ID: 15719069
[TBL] [Abstract][Full Text] [Related]
20. Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells.
Lee HY; Chaudhary J; Walsh GL; Hong WK; Kurie JM
Oncogene; 1998 Jun; 16(23):3039-46. PubMed ID: 9662337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
